Jonathan Biller, EVP and Chief Legal Officer at Vertex Pharmaceuticals ($VRTX), sold about $4.1 million in company shares through seven open market transactions over the past year. His most recent sale occurred on February 25, 2026. These sales rank 2,224th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. Biller made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1144 | $485.11 | 14,604.0000 | 258,000,000 | 7.26% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 945 | $486.35 | 13,659.0000 | 258,000,000 | 6.47% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 2476 | $489.46 | 16,992.0000 | 258,000,000 | 12.72% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1505 | $483.75 | 19,468.0000 | 258,000,000 | 7.18% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4135 | $0.00 | 20,973.0000 | 258,000,000 | 24.56% | 0.00% |
| Feb. 18, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1244 | $473.68 | 15,748.0000 | 258,000,000 | 7.32% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 2993 | $487.76 | 17,826.0000 | 258,000,000 | 14.38% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 988 | $499.00 | 16,838.0000 | 258,000,000 | 5.54% | 0.00% |
| Feb. 11, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1925 | $460.43 | 20,819.0000 | 258,000,000 | 8.46% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1630 | $468.41 | 22,744.0000 | 258,000,000 | 6.69% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 2774 | $0.00 | 24,374.0000 | 258,000,000 | 12.84% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 6294 | $0.00 | 21,600.0000 | 258,000,000 | 41.12% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 347 | $449.00 | 15,306.0000 | 258,600,000 | 2.22% | 0.00% |
| Oct. 2, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 694 | $404.21 | 15,653.0000 | 258,600,000 | 4.25% | 0.00% |
| Oct. 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1259 | $400.00 | 16,347.0000 | 258,600,000 | 7.15% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1504 | $463.46 | 19,263.0000 | 257,899,999 | 7.24% | 0.00% |
| Feb. 18, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1657 | $455.06 | 17,606.0000 | 257,899,999 | 8.60% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4437 | $0.00 | 20,767.0000 | 257,899,999 | 27.17% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1632 | $467.98 | 19,763.0000 | 257,899,999 | 7.63% | 0.00% |
| Feb. 11, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 3433 | $459.87 | 16,330.0000 | 257,899,999 | 17.37% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4744 | $0.00 | 21,395.0000 | 257,899,999 | 28.49% | 0.00% |
| Oct. 2, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 999 | $461.66 | 16,651.0000 | 261,000,000 | 5.66% | 0.00% |
| Oct. 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 630 | $466.84 | 17,650.0000 | 261,000,000 | 3.45% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1738 | $418.77 | 18,280.0000 | 260,500,000 | 8.68% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1588 | $422.74 | 20,018.0000 | 260,500,000 | 7.35% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4743 | $0.00 | 21,606.0000 | 260,500,000 | 28.13% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 6294 | $0.00 | 16,863.0000 | 260,500,000 | 59.55% | 0.00% |